Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (51-60 of 298) with videos related to

Pageof 30
Sort By:
Proceedings (Baylor University. Medical Center)|April 14, 2017
Evaluation and management of an unusual congenital nevusK Blaire Kerwin, M Alan Menter
Clinical, Cosmetic and Investigational Dermatology|May 24, 2019
Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to dateDario Kivelevitch, Sima Amin, Alan Menter
Proceedings (Baylor University. Medical Center)|May 1, 2018
Symptomatic hypercalcemia and scarring alopecia as presenting features of sarcoidosisJillian Frieder, Dario Kivelevitch, Alan Menter
Journal of the American Academy of Dermatology|March 21, 2006
Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspectivePhilip J Mease, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Leg lesions and velvety hyperpigmentation on the neckJennifer Clay Cather, M Alan Menter
Biologics : Targets & Therapy|May 3, 2014
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritisDario Kivelevitch, Bobbak Mansouri, Alan Menter
Expert Opinion on Emerging Drugs|February 4, 2015
Emerging oral drugs for psoriasisTahmina Mahmood, Daniel Zaghi, Alan Menter
JAMA Dermatology|January 22, 2015
Polymorphic blistering eruption and stomatitis in a patient with non-Hodgkin lymphomaTahmina Mahmood, Mary Horner, Alan Menter
Expert Opinion on Biological Therapy|October 29, 2013
Biological therapies for psoriasisBobbak Mansouri, Mahir Patel, Alan Menter
The Journal of Dermatological Treatment|April 16, 2016
Pustular psoriasis eruption with dabrafenib, a BRAF inhibitorBilal Fawaz, Lauren Dickson, Alan Menter
Pageof 30

Showing results (51-60 of 298) with videos related to

Sort By:
Pageof 30
Proceedings (Baylor University. Medical Center)|April 14, 2017
Evaluation and management of an unusual congenital nevusK Blaire Kerwin, M Alan Menter
Clinical, Cosmetic and Investigational Dermatology|May 24, 2019
Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to dateDario Kivelevitch, Sima Amin, Alan Menter
Proceedings (Baylor University. Medical Center)|May 1, 2018
Symptomatic hypercalcemia and scarring alopecia as presenting features of sarcoidosisJillian Frieder, Dario Kivelevitch, Alan Menter
Journal of the American Academy of Dermatology|March 21, 2006
Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspectivePhilip J Mease, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Leg lesions and velvety hyperpigmentation on the neckJennifer Clay Cather, M Alan Menter
Biologics : Targets & Therapy|May 3, 2014
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritisDario Kivelevitch, Bobbak Mansouri, Alan Menter
Expert Opinion on Emerging Drugs|February 4, 2015
Emerging oral drugs for psoriasisTahmina Mahmood, Daniel Zaghi, Alan Menter
JAMA Dermatology|January 22, 2015
Polymorphic blistering eruption and stomatitis in a patient with non-Hodgkin lymphomaTahmina Mahmood, Mary Horner, Alan Menter
Expert Opinion on Biological Therapy|October 29, 2013
Biological therapies for psoriasisBobbak Mansouri, Mahir Patel, Alan Menter
The Journal of Dermatological Treatment|April 16, 2016
Pustular psoriasis eruption with dabrafenib, a BRAF inhibitorBilal Fawaz, Lauren Dickson, Alan Menter
Pageof 30